Hysteroscopic treatments for endometrial malignancies and premalignancies: state of the art

References

• Amant F, Mirza MR, Koskas M, et al. Cancer of the corpus uteri. FIGO Cancer Report 2018. Int J Gynecol Obstet. 2018;143:37–50.
   PubMed Web of Science ®Google Scholar
• Rasool N, Rose PG. Fertility-preserving surgical procedures for patients with gynecologic malignancies. Clin Obstet Gynecol. 2010;53(4):804–814.
   PubMed Web of Science ®Google Scholar
• Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105(3):575–580.
   PubMed Web of Science ®Google Scholar
• Lee TS, Kim JW, Kim TJ, et al. Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group. Gynecol Oncol. 2009;115(1):26–31.
   PubMed Web of Science ®Google Scholar
• Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13(3):295–308.
   PubMed Web of Science ®Google Scholar
• Ushijima K, Yahata H, Yoshikawa H, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25(19):2798–2803.
   PubMed Web of Science ®Google Scholar
• Pal N, Broaddus RR, Urbauer DL, et al. Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device. Obstet Gynecol. 2018;131(1):109–116.
   PubMed Web of Science ®Google Scholar
• Trimble CL, Method M, Leitao M, et al. Management of endometrial precancers. Obstet Gynecol. 2012;120(5):1160–1175.
   PubMed Web of Science ®Google Scholar
• Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106(4):812–819.
   PubMed Web of Science ®Google Scholar
• Salman MC, Usubutun A, Boynukalin K, et al. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. J Gynecol Oncol. 2010;21(2):97–101.
   PubMed Web of Science ®Google Scholar
• Gallos ID, Yap J, Rajkhowa M, et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207(4):266.e1–266.12.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Bruni S, Chiofalo B, et al. Updates in office hysteroscopy: a practical decalogue to perform a correct procedure. Updates Surg. 2020;72(4):967–976.
   PubMed Web of Science ®Google Scholar
• Saccardi C, Vitagliano A, Marchetti M, et al. Endometrial cancer risk prediction according to indication of diagnostic hysteroscopy in post-menopausal women. Diagnostics (Basel). 2020;10(5):257.
   Google Scholar
• Vitale SG, Riemma G, Carugno J, et al. Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives. Transl Cancer Res Tcr. 2020;9(12):7767–7767.
   Web of Science ®Google Scholar
• Vitale SG, Haimovich S, Riemma G, et al. Innovations in hysteroscopic surgery: expanding the meaning of “in-office”. Minim Invasive Ther Allied Technol. 2021;30(3):125–132.
   PubMed Web of Science ®Google Scholar
• Guillon S, Popescu N, Phelippeau J, et al. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma. Int J Gynecol Obstet. 2019;146(3):277–288.
   PubMed Web of Science ®Google Scholar
• De Franciscis P, Riemma G, Schiattarella A, et al. Concordance between the hysteroscopic diagnosis of endometrial hyperplasia and histopathological examination. Diagnostics (Basel). 2019;9:142.
   Google Scholar
• Vitale SG. The Biopsy Snake Grasper Sec. VITALE: a new tool for office hysteroscopy. J Minim Invasive Gynecol. 2020;27(6):1414–1416.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Laganà AS, Caruso S, et al. Comparison of three biopsy forceps for hysteroscopic endometrial biopsy in postmenopausal patients (HYGREB-1): a multicenter, single-blind randomized clinical trial. Int J Gynaecol Obstet. 2021;  doi: 10.1002/ijgo.13669.
   Web of Science ®Google Scholar
• Mazzon I, Corrado G, Morricone D, et al. Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection. Int J Gynecol Cancer. 2005;15(5):974–978.
   PubMed Web of Science ®Google Scholar
• Mazzon I, Corrado G, Masciullo V, et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2010;93(4):1286–1289.
   PubMed Web of Science ®Google Scholar
• Shan BE, Ren YL, Sun JM, et al. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women. Arch Gynecol Obstet. 2013;288(5):1115–1123.
   PubMed Web of Science ®Google Scholar
• De Marzi P, Bergamini A, Luchini S, et al. Hysteroscopic resection in fertility-sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy. J Minim Invasive Gynecol. 2015;22(7):1178–1182.
   PubMed Web of Science ®Google Scholar
• Wang Q, Guo Q, Gao S, et al. Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young women. Int J Clin Exp Med. 2015;8(8):13804–13810.
   PubMed Web of Science ®Google Scholar
• Falcone F, Laurelli G, Losito S, et al. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J Gynecol Oncol. 2017;28(1):e2.
   PubMed Web of Science ®Google Scholar
• Wang F, Yu A, Xu H, et al. Fertility preserved hysteroscopic approach for the treatment of stage Ia endometrioid carcinoma. Int J Gynecol Cancer. 2017;27(9):1919–1925.
   PubMed Web of Science ®Google Scholar
• Giampaolino P, Di Spiezio Sardo A, Mollo A, et al. Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study. J Minim Invasive Gynecol. 2019;26(4):648–656.
   PubMed Web of Science ®Google Scholar
• Yang B, Xu Y, Zhu Q, et al. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecol Oncol. 2019;153(1):55–62.
   PubMed Web of Science ®Google Scholar
• Ayhan A, Tohma YA, Tunc M. Fertility preservation in early-stage endometrial cancer and endometrial intraepithelial neoplasia: a single-center experience. Taiwan J Obstet Gynecol. 2020;59(3):415–419.
   PubMed Web of Science ®Google Scholar
• Falcone F, Leone Roberti Maggiore U, Di Donato V, et al. Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study. J Gynecol Oncol. 2020;31(5):e74.
   PubMed Web of Science ®Google Scholar
• Gunderson CC, Fader AN, Carson KA, et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125(2):477–482.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Qi G, Kanis MJ, et al. Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia. Oncotarget. 2017;8(34):57642–57653.
   PubMedGoogle Scholar
• Laurelli G, Di Vagno G, Scaffa C, et al. Conservative treatment of early endometrial cancer: preliminary results of a pilot study. Gynecol Oncol. 2011;120(1):43–46.
   PubMed Web of Science ®Google Scholar
• Talhouk A, Hoang LN, McConechy MK, et al. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment. Gynecol Oncol. 2016;143(1):46–53.
   PubMed Web of Science ®Google Scholar
• Travaglino A, Raffone A, Saccone G, et al. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review. Acta Obstet Gynecol Scand. 2019;98(9):1086–1099.
   PubMed Web of Science ®Google Scholar
• Travaglino A, Raffone A, Saccone G, et al. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018;231:104–110.
   PubMed Web of Science ®Google Scholar
• Raffone A, Travaglino A, Zullo FM, et al. Predictive accuracy of progesterone receptor B in young women with atypical endometrial hyperplasia and early endometrial cancer treated with hysteroscopic resection plus LNG-IUD insertion. J Minim Invasive Gynecol. 2020; Oct 26:S1553-4650(20)31097-9.
   PubMed Web of Science ®Google Scholar
• Raffone A, Travaglino A, Saccone G, et al. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2019;98(8):976–987.
   PubMed Web of Science ®Google Scholar
• Polyzos NP, Mauri D, Tsioras S, et al. Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis. Int J Gynecol Cancer. 2010;20(2):261–267.
   PubMed Web of Science ®Google Scholar
• Baker VL, Adamson GD. Threshold intrauterine perfusion pressures for intraperitoneal spill during hydrotubation and correlation with tubal adhesive disease. Fertil Steril. 1995;64(6):1066–1069.
   PubMed Web of Science ®Google Scholar
• Leveque J, Goyat F, Dugast J, et al. Value of peritoneal cytology after hysteroscopy in surgical stage I adenocarcinoma of the endometrium. Oncol Rep. 1998;5(3):713–715.
   PubMed Web of Science ®Google Scholar
• Chang YN, Zhang Y, Wang YJ, et al. Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis. Fertil Steril. 2011;96(4):957–961.
   PubMed Web of Science ®Google Scholar
• Manchanda R, Valenti G, Rathore A, et al. Distension media delivery systems in hysteroscopy: past, present and future. Minim Invasive Ther Allied Technol. 2020;   doi: https://doi.org/10.1080/13645706.2020.1763402.
   Google Scholar
• AAGL Advancing Minimally Invasive Gynecology Worldwide, Munro MG, Storz K, et al. AAGL practice report: practice guidelines for the management of hysteroscopic distending media: (Replaces Hysteroscopic Fluid Monitoring Guidelines. J Am Assoc Gynecol Laparosc. 2000;7:167–168.). J Minim Invasive Gynecol. 2013;20:137–148.
   PubMed Web of Science ®Google Scholar
• Giampaolino P, Della Corte L, Di Filippo C, et al. Office hysteroscopy in the management of women with postmenopausal bleeding. Climacteric. 2020;23(4):369–375.
   PubMed Web of Science ®Google Scholar
• Sugimoto O. Hysteroscopic diagnosis of endometrial carcinoma. A report of fifty-three cases examined at the women’s clinic of KyotoUniversity Hospital. Am J Obstet Gynecol. 1975;121(1):105–113.
   PubMed Web of Science ®Google Scholar
• Iha T, Shen H, Kanazawa K. Hysteroscopy to detect Stage IA well-differentiated endometrioid adenocarcinoma of the endometrium. Acta Obstet Gynecol Scand. 2003;82(4):378–384.
   PubMed Web of Science ®Google Scholar
• Garuti G, De Giorgi O, Sambruni I, et al. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma. Gynecol Oncol. 2001;81(3):408–413.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Mizutani H, Torashima M, et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR Am J Roentgenol. 1993;161(3):595–599.
   PubMed Web of Science ®Google Scholar